Market Research Logo

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - South Korea

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - South Korea

Summary

GlobalData, the industry analysis specialist, has released its latest report, CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - South Korea. The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in South Korea. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of South Korea. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

South Korea is a growing pharmaceutical market with a strong focus on biosimilars and domestic pharmaceutical manufacturing. The value of the pharmaceutical market increased from $16.7bn in 2010 to $18.7bn in 2016, at a Compound Annual Growth Rate (CAGR) of 2%. It is forecast to reach $23.2bn by 2022. The medical device market was valued at $4.4bn in 2010, which increased to $7bn in 2017. It is expected to grow at a CAGR of 8.8% from $7.5bn in 2018 to $10.5bn in 2022. South Korea has free trade agreements with the US, EU and India. These agreements help in eliminating trade barriers and attracting foreign investment. In 2017, foreign companies invested $352m in pharmaceutical manufacturing in South Korea.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in South Korea, and includes -

  • An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
  • Profiles and SWOT analyses of the major players in the pharmaceutical market (Pfizer, Merck, Novartis, AstraZeneca, Daewoong Pharmaceutical and Celltrion) and profiles and SWOT analyses of the major players in the medical device market (GE Healthcare, Stryker, Boston Scientific, Alcon and i-Sens)
  • Detailed analysis about recent completed deals in the pharmaceutical and medical device market of South Korea
  • Porter’s five forces analysis for pharmaceutical and medical devices market of South Korea
  • An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
  • Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure
  • An overview of the opportunities for and challenges to growth in the South Korean healthcare market.
Reasons to buy

This report will enhance your decision-making capability by allowing you to -
  • Develop business strategies by understanding the trends shaping and driving the South Korean healthcare market
  • Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
  • Identify, understand, and capitalize on the opportunities and challenges in the South Korean healthcare market.


Executive Summary
Overview of Pharmaceutical Market
Overview of Medical Device Market
Deals Analysis
Porter’s Five Forces Model
Market Access
Country Healthcare Landscape
Opportunities and Challenges
Appendix
List of Tables
Table 1: Approved Biosimilars. South Korea, 2018
Table 2: Pharmaceutical Market, South Korea, Therapeutic Area by Production Amount ($bn), 2016
Table 3: Diagnostic Imaging Devices Market, South Korea, Revenue ($m) and Market Share (%) of Major Companies, 2015
Table 4: Ophthalmic Devices Market, South Korea, Revenue ($m) and Market Share (%) of Major Companies, 2015
Table 5: Cardiovascular Devices Market, South Korea, Revenue ($m) and Market Share (%) of Major Companies, 2017
Table 6: Dental Devices Market, South Korea, Revenue ($m) and Market Share (%) of Major Companies, 2017
Table 7: Orthopedic Devices Market, South Korea, Revenue ($m) and Market Share (%) of Major Companies, 2017
Table 8: Merger and Acquisition Deals, Medical Device Market, South Korea, 2017-2018
Table 9: Private Equity, Deals, Medical Device Market, South Korea, 2017-2018
Table 10: National Insurance Contribution Rates, South Korea, 2016
Table 11: Long-Term Care Insurance System vs Previous Elderly Benefit Service System, South Korea, 2016
Table 12: Co-payments, South Korea, 2015
Table 13: Medical Device Classification, South Korea, 2015
Table 14: Patent Fees, South Korea, 2017
Table 15: Trademark Fees, South Korea, 2017
Table 16: Drug Container and Package Information, South Korea, 2017
Table 17: Package Insert Information, South Korea, 2017
Table 18: Trade Fairs, South Korea, 2018-2019
List of Figures
Figure 1: Pharmaceutical Market, South Korea, Revenue ($bn), 2010-2017
Figure 2: Medical Device Market, South Korea, Revenue ($bn), 2010-2017
Figure 3: Country Profile, South Korea, 2017
Figure 4: Pharmaceutical Market, South Korea, Revenue ($bn), 2010-2017
Figure 5: Pharmaceutical Market, South Korea, Revenue Forecast ($bn), 2018-2022
Figure 6: Pharmaceutical Exports ($bn), South Korea, 2010-2016
Figure 7: Top Export Partners, South Korea, 2016
Figure 8: Pharmaceutical Imports ($bn), South Korea, 2010-2016
Figure 9: Top Import Partners, South Korea, 2016
Figure 10: Process of Assigning KD code, South Korea, 2018
Figure 11: Drug Supply and Report Process of Drug Transaction Records, South Korea, 2016
Figure 12: Pharmaceutical Market, South Korea, Therapeutic Area by Production Amount($bn), 2016
Figure 13: Pharmaceutical Market, South Korea, Major Players
Figure 14: Medical Device Market, South Korea, Revenue ($bn), 2010-2017
Figure 15: Medical Device Market, South Korea, Revenue Forecast ($bn), 2018-2022
Figure 16: Medical Device Market, South Korea, Revenue by Segment ($m), 2017
Figure 17: Diagnostic Imaging Devices Market, South Korea, Revenue ($m), 2010-2017
Figure 18: Diagnostic Imaging Devices Market, South Korea, Market Share of Major Players (%), 2015
Figure 19: Ophthalmic Devices Market, South Korea, Revenue ($m), 2010-2017
Figure 20: Ophthalmic Devices Market, South Korea, Market Share of Major Players (%), 2015
Figure 21: Cardiovascular Devices Market, South Korea, Revenue ($bn), 2010-2017
Figure 22: Cardiovascular Devices Market, South Korea, Market Share of Major Players (%), 2017
Figure 23: Dental Devices Market, South Korea, Revenue ($m), 2010-2017
Figure 24: Dental Devices Market, South Korea, Market Share of Major Players (%), 2017
Figure 25: Orthopedic Devices Market, South Korea, Revenue ($m), 2010-2017
Figure 26: Orthopedic Devices Market, South Korea, Market Share of Major Companies (%), 2017
Figure 27: Diagnostic Market, South Korea, Revenue ($m), 2010-2017
Figure 28: Diagnostic Market, South Korea, Revenue ($m), 2018-2022
Figure 29: Medical Device Market, South Korea, Revenue ($bn) of Major Companies, 2017
Figure 30: Deal Value and Deal Count, Pharmaceutical Market, South Korea, 2017-2018
Figure 31: Deal Value and Deal Count Quarterly, Pharmaceutical Market, South Korea, 2017-2018
Figure 32: Deal Value and Deal Count Sub-types, Pharmaceutical Market, South Korea, 2017-2018
Figure 33: Pharmaceutical Market, South Korea, Top Five Therapy Areas by Deal Value ($m), 2017-2018
Figure 34: Pharmaceutical Market, South Korea, Top Five Therapy Areas by Deal Number, 2017-2018
Figure 35: Pharmaceutical Market, South Korea, Venture Financing Deals by Therapy Area, 2017-2018
Figure 36: Medical Device Market Deals (by deal value, $m), South Korea, 2017-2018
Figure 37: Medical Device Market Deals (by deal count), South Korea, 2017-2018
Figure 38: Medical Device Market Deals Share (by deal count), South Korea, 2017-2018
Figure 39: Medical Device Market Deals Share (by deal value), South Korea, 2017-2018
Figure 40: Health Care System, South Korea, 2018
Figure 41: Organization Structure of the NHIS, South Korea, 2018
Figure 42: Positive and Negative List, South Korea, 2018
Figure 43: Drug Reimbursement Process, South Korea, 2018
Figure 44: Medical Device Reimbursement, South Korea, 2018
Figure 45: National Insurance Contribution Score Calculation, South Korea, 2016
Figure 46: Structure of National Health Insurance, South Korea, 2016
Figure 47: Out-of-Pocket Expenditure (% of total expenditure on health), South Korea, 2010-2017
Figure 48: Annual Rate of Change (%), Health Price Index, South Korea, 2010-2017
Figure 49: New Drug Pricing, South Korea, 2015
Figure 50: Ministry of Food and Drug Safety, Organization Chart, 2017
Figure 51: National Institute of Food and Drug Safety Evaluation, Organization Chart, 2017
Figure 52: New Drug Approval Process, South Korea, 2017
Figure 53: Generic Drug Approval Process, South Korea, 2017
Figure 54: Premarket Approval Process, South Korea, 2017
Figure 55: Medical Device Approval Process, South Korea, 2017
Figure 56: Patent Approval Process, South Korea, 2016
Figure 57: Trademark Process, South Korea, 2016
Figure 58: Clinical Trial Regulation, South Korea, 2017
Figure 59: Hospitals (Number), South Korea, 2010-2017
Figure 60: Hospitals by Type (Number), South Korea, 2010-2017
Figure 61: Diagnostic Equipment (per million population), South Korea,2010-2017
Figure 62: Hospital Beds (per 1,000 population), South Korea, 2010-2017
Figure 63: Acute Care Hospital Beds (per 1,000 population), South Korea, 2010-2017
Figure 64: Psychiatric Hospital Beds (per 1,000 population), South Korea, 2010-2017
Figure 65: Life Expectancy (in years), South Korea, 2010-2017
Figure 66: Immunization Rate (%), South Korea, 2010-2017
Figure 67: PM2.5 (μg per m3), South Korea, 2010-2017
Figure 68: CO2 Emissions (metric tons per capita), South Korea, 2010-2017
Figure 69: Physicians (per 1,000 population), South Korea, 2010-2017
Figure 70: Nurses (per 1,000 population), South Korea, 2010-2017
Figure 71: Dentists, (per 1,000 population), South Korea, 2010-2017
Figure 72: Pharmacists, (per 1,000 population), South Korea, 2010-2017
Figure 73: Major Causes of Mortality (number of deaths, ‘000), South Korea, 2015
Figure 74: Major Causes of Male Mortality (number of deaths, ‘000), South Korea, 2015
Figure 75: Major Causes of Female Mortality (number of deaths, ‘000), South Korea, 2015
Figure 76: Disability-Adjusted Life Years by Major Disease (‘000), South Korea, 2015
Figure 77: Healthcare Expenditure as Percentage of GDP (%), South Korea, 2010-2017
Figure 78: Public-Private Share (%), South Korea, 2010-2017
Figure 79: Healthcare Expenditure by Providers (%), South Korea, 2016
Figure 80: Healthcare Expenditure by Function (%), South Korea, 2016
Figure 81: Opportunities and Challenges, South Korea

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report